These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35811799)

  • 21. Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis.
    Ferreira LS; Darcie Marquitti FM; Paixão da Silva RL; Borges ME; Ferreira da Costa Gomes M; Cruz OG; Kraenkel RA; Coutinho RM; Prado PI; Bastos LS
    Lancet Reg Health Am; 2023 Jan; 17():100397. PubMed ID: 36439909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021.
    Machado A; Kislaya I; Rodrigues AP; Sequeira D; Lima J; Cruz C; Leite PP; Matias Dias C; Nunes B
    PLoS One; 2022; 17(9):e0274008. PubMed ID: 36099273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of hospitalizations and in-hospital deaths from COVID-19 in northeast Brazil: a retrospective analysis based on the circulation of SARS-CoV-2 variants and vaccination coverage.
    Martins-Filho PR; de Souza Araújo AA; Quintans-Júnior LJ; Soares BDS; Barboza WS; Cavalcante TF; Santos VS
    Epidemiol Health; 2022; 44():e2022036. PubMed ID: 35413166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial.
    Zhu P; Tatar O; Griffin-Mathieu G; Perez S; Haward B; Zimet G; Tunis M; Dubé È; Rosberger Z
    JMIR Public Health Surveill; 2022 May; 8(5):e37328. PubMed ID: 35544437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [COVID-19 and older adults: spatiotemporal comparison between mortality and vaccination in the province of Buenos Aires, Argentina].
    Leveau CM; Velázquez GA
    Rev Peru Med Exp Salud Publica; 2021; 38(4):601-607. PubMed ID: 35385013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.
    Diesel J; Sterrett N; Dasgupta S; Kriss JL; Barry V; Vanden Esschert K; Whiteman A; Cadwell BL; Weller D; Qualters JR; Harris L; Bhatt A; Williams C; Fox LM; Meaney Delman D; Black CL; Barbour KE
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(25):922-927. PubMed ID: 34166331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quasi-experimental evaluation of a financial incentive for first-dose COVID-19 vaccination among adults aged ≥60 years in South Africa.
    Chetty-Makkan CM; Thirumurthy H; Bair EF; Bokolo S; Day C; Wapenaar K; Werner J; Long L; Maughan-Brown B; Miot J; Pascoe SJS; Buttenheim AM
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36543383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    Britton A; Fleming-Dutra KE; Shang N; Smith ZR; Dorji T; Derado G; Accorsi EK; Ajani UA; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Mar; 327(11):1032-1041. PubMed ID: 35157002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population Immunity Against COVID-19 in the United States.
    Moghadas SM; Sah P; Shoukat A; Meyers LA; Galvani AP
    Ann Intern Med; 2021 Nov; 174(11):1586-1591. PubMed ID: 34516275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco.
    Zhang Y; Belayachi J; Yang Y; Fu Q; Rodewald L; Li H; Yan B; Wang Y; Shen Y; Yang Q; Mu W; Tang R; Su C; Xu T; Obtel M; Mhayi A; Razine R; Abouqal R; Zhang Y; Yang X
    BMC Public Health; 2022 Aug; 22(1):1584. PubMed ID: 35987605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early impact of COVID-19 vaccination on older populations in four countries of the Americas, 2021.
    Jarquin C; Quezada LF; Gobern L; Balsells E; Rondy M
    Rev Panam Salud Publica; 2023; 47():e122. PubMed ID: 37564919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    Semenzato L; Botton J; Baricault B; Deloumeaux J; Joachim C; Sylvestre E; Dray-Spira R; Weill A; Zureik M
    PLoS One; 2022; 17(9):e0274309. PubMed ID: 36084113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 mortality in two waves of the pandemic in Cali, Colombia, before and during vaccination roll-out.
    Reina C; Roa P; Garcés A; Valencia A; Torres M; Concha-Eastman A
    Rev Panam Salud Publica; 2023; 47():e76. PubMed ID: 37223328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study.
    Tzur Bitan D; Kridin K; Cohen AD; Weinstein O
    Lancet Psychiatry; 2021 Oct; 8(10):901-908. PubMed ID: 34364406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels.
    Mohr-Sasson A; Haas J; Abuhasira S; Sivan M; Doitch Amdurski H; Dadon T; Blumenfeld S; Derazne E; Hemi R; Orvieto R; Afek A; Rabinovici J
    Hum Reprod; 2022 Mar; 37(3):534-541. PubMed ID: 34935913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.